{
  "symbol": "ABBV",
  "year": 2022,
  "period": "Q2",
  "curated_text": "Symbol: ABBV. Year: 2022. Period: Q2. ReportType: Q10. Section: Competition and Market Position. This section discusses competitors, market dynamics, and regulatory landscape.  Competitors mentioned: the California Business and Professions Code, AndroGel, King Drug Co., Florence, Inc., Solvay Pharmaceuticals, Inc., Abbott, sham litigation, Perrigo Company, Abbott\u2019s, Perrigo, Humira, Adalimumab, Antitrust Litigation, Forest Laboratories, LLC, Forest, Namenda, Allergan Inc., the U.S. Patent Office and Food and Drug Administration, Restasis, Bystolic Antitrust Litigation, MDL, Prescription Opiate Litigation, the State of West Virginia, State of New Mexico, Balderas v. AbbVie Inc., New Mexico\u2019s Unfair Practices Act, the New Mexico False Advertising Act, Shareholder and Securities Litigation, Elliott Associates, Illinois Circuit Court, Shire, the Illinois Appellate Court, the New York Supreme Court, the Supreme Court of New York, Appellate Division, Holwill, Delaware Chancery Court, Allergan plc Securities Litigation, Nakata, the Food and Drug Administration\u2019s, Treppel Family Trust, the U.S. Patent Office, Intellectual Property Litigation Pharmacyclics LLC, Alvogen Pine Brook LLC, Allergan USA, Inc., Forest Laboratories Holdings Limited, Sun Pharmaceutical Industries Limited, Sun Pharma Global FZE, Aurobindo Pharma Limited, Zydus Pharmaceuticals, Cadila Healthcare Limited, Plc, Inc., Vraylar, CODM, Hematologic Oncology Imbruvica, Vraylar United States, Eye Care Lumigan/Ganfort United States, Linzess/Constella United, ANALYSIS OF FINANCIAL CONDITION, AbbVie Inc., the Condensed Consolidated Financial Statements, Supplementary Data, North Atlantic Treaty Organization, Botox, COVID-19, Research and Development Research, the U.S. Food and Drug Administration, FDA, New Drug Application, NSAIDs, bVie, the European Commission, EC, the European Medicines Agency, EMA, JAK, U-Excel, Rinvoq, TNF, U-ENDURE, MAA, Breakthrough Therapy Designation, Imbruvica \u2022, Genmab A/S (Genmab, DuoBody-CD3xCD20, Eye Care Vuity \u2022, the Phase 3, Vuity, Percent, United States, Imbruvica, Venclexta, CLL, Botox Cosmetic, Juvederm Collection, Botox Therapeutic, SG&A, litigation reserve, Syndesi Therapeutics SA, Consolidated Financial Statements, Non-Operating Expenses (Income, LIQUIDITY, Credit Risk AbbVie. Context excerpt: competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott acquired in February 2010 and now known as AbbVie Products LLC) with three generic companies violated federal antitrust law, and also alleging that 2011 patent litigation by Abbott with two generic companies regarding AndroGel was sham litigation and the settlements of those litigations violated federal antitrust law. Plaintiffs generally seek monetary damages and/or injunctive relief and attorneys\u2019 fees. In May 2020, Perrigo Company and related entities filed a lawsuit against AbbVie and others",
  "competition_summary": [
    {
      "competitor": "the California Business and Professions Code",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "AndroGel",
      "mentions": 4,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "King Drug Co.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Florence, Inc.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Solvay Pharmaceuticals, Inc.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Abbott",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "sham litigation",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Perrigo Company",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Abbott\u2019s",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Perrigo",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Humira",
      "mentions": 8,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Adalimumab",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Antitrust Litigation",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Forest Laboratories",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "LLC",
      "mentions": 3,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Forest",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Namenda",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Allergan Inc.",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the U.S. Patent Office and Food and Drug Administration",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Restasis",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Bystolic Antitrust Litigation",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "MDL",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Prescription Opiate Litigation",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the State of West Virginia",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "State of New Mexico",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Balderas v. AbbVie Inc.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "New Mexico\u2019s Unfair Practices Act",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the New Mexico False Advertising Act",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Shareholder and Securities Litigation",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Elliott Associates",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Illinois Circuit Court",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Shire",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the Illinois Appellate Court",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the New York Supreme Court",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the Supreme Court of New York",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Appellate Division",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Holwill",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Delaware Chancery Court",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Allergan plc Securities Litigation",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Nakata",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the Food and Drug Administration\u2019s",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Treppel Family Trust",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the U.S. Patent Office",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Intellectual Property Litigation Pharmacyclics LLC",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Alvogen Pine Brook LLC",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Allergan USA, Inc.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Forest Laboratories Holdings Limited",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Sun Pharmaceutical Industries Limited",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Sun Pharma Global FZE",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Aurobindo Pharma Limited",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Zydus Pharmaceuticals",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Cadila Healthcare Limited",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Plc, Inc.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Vraylar",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "CODM",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Hematologic Oncology Imbruvica",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Vraylar United States",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Eye Care Lumigan/Ganfort United States",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Linzess/Constella United",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "ANALYSIS OF FINANCIAL CONDITION",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "AbbVie Inc.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the Condensed Consolidated Financial Statements",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Supplementary Data",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "North Atlantic Treaty Organization",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Botox",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "COVID-19",
      "mentions": 5,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Research and Development Research",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the U.S. Food and Drug Administration",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "FDA",
      "mentions": 15,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "New Drug Application",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "NSAIDs",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "bVie",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the European Commission",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "EC",
      "mentions": 3,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the European Medicines Agency",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "EMA",
      "mentions": 3,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "JAK",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "U-Excel",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Rinvoq",
      "mentions": 4,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "TNF",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "U-ENDURE",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "MAA",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Breakthrough Therapy Designation",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Imbruvica \u2022",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Genmab A/S (Genmab",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "DuoBody-CD3xCD20",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Eye Care Vuity \u2022",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the Phase 3",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Vuity",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Percent",
      "mentions": 6,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "United States",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Imbruvica",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Venclexta",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "CLL",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Botox Cosmetic",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Juvederm Collection",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Botox Therapeutic",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "SG&A",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "litigation reserve",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Syndesi Therapeutics SA",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Consolidated Financial Statements",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Non-Operating Expenses (Income",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "LIQUIDITY",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Credit Risk AbbVie",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    }
  ]
}